Seasonal Allergic Rhinitis
📧 Sign up to get email alerts when something new happens for Seasonal Allergic Rhinitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-02-05Clinical Trial Update: Treatment of Ragweed-Allergic Asthma With an Immunostimulatory Drug [Phase 2]
This update reports the termination of a Phase 2 trial evaluating an immunostimulatory drug for ragweed-induced asthma.
-
FDA approval · 2013-01-31FDA Approved: MONTELUKAST — Supplemental Application (Sandoz Inc)
FDA approved a supplemental application from Sandoz Inc. for montelukast, granting approval of changes to the generic montelukast product un…
-
FDA approval · 2013-01-31FDA Approved: MONTELUKAST SODIUM — Supplemental Application (Lannett Company, Inc.)
FDA approved a supplemental application for Montelukast sodium from Lannett Company, Inc., allowing continued marketing of the generic produ…
-
CLINICAL_TRIALS trial_result · 2013-01-29Clinical Trial Update: Effects of Phenylephrine Extended-Release Tablets on Allergy-Related Nasal Congestion (P08498 AM1) [Phase 3]
Phase 3 trial assessing phenylephrine extended-release tablets on allergy-related nasal congestion in Seasonal Allergic Rhinitis. Results ha…
-
FDA approval · 2012-12-17FDA Approved: MONTELUKAST SODIUM — Supplemental Application (Accord Healthcare Inc.)
FDA approved a supplemental application for Montelukast Sodium by Accord Healthcare Inc., resulting in an approved modification to the produ…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2012-11-27Clinical Trial Update: Efficacy and Safety Study of a Sublingual Immunotherapy Solution to Treat Patients Suffering From Birch Pollen Allergic Rhinoconjunctivitis [Phase 3]
Phase 3 clinical trial evaluating the efficacy and safety of a sublingual immunotherapy solution for birch pollen–induced allergic rhinoconj…
-
CLINICAL_TRIALS trial_result · 2012-11-07Clinical Trial Update: Effects of Phenylephrine on Nasal Congestion in Participants With Seasonal Allergic Rhinitis (P08156 AM2)(Completed) [Phase 2]
A Phase 2 trial assessed phenylephrine for reducing nasal congestion in adults with seasonal allergic rhinitis; results were posted after co…
-
CLINICAL_TRIALS trial_result · 2012-10-23Clinical Trial Update: Acupuncture for Seasonal Allergic Rhinitis [NA]
This is a completed clinical trial update for acupuncture in seasonal allergic rhinitis. The sponsor is Charite University in Berlin.
-
FDA approval · 2012-10-18FDA Approved: SINGULAIR — Supplemental Application (Organon LLC)
FDA approved a supplemental application for Singulair (montelukast sodium) submitted by Organon LLC.
-
FDA approval · 2012-10-16FDA Approved: MONTELUKAST SODIUM — Supplemental Application (Torrent Pharmaceuticals Limited)
FDA approved a supplemental application for montelukast sodium from Torrent Pharmaceuticals Limited, enabling the generic product to be mark…
-
CLINICAL_TRIALS trial_result · 2012-10-04Clinical Trial Update: Compare Captisol-Enabled (CE) Budesonide + Azelastine Nasal Solution and Rhinocort Aqua + Astelin in an Environmental Exposure Chamber (EEC) Study of Allergic Rhinitis [Phase 2]
Phase 2 environmental exposure chamber study comparing Captisol-enabled budesonide plus azelastine nasal solution with Rhinocort Aqua plus a…
-
CLINICAL_TRIALS trial_result · 2012-10-04Clinical Trial Update: Compare CE-Budesonide Nasal Solution & Rhinocort Aqua in an EEC Study of AR [Phase 2]
This Phase 2 trial compared CE-Budesonide Nasal Solution to Rhinocort Aqua for seasonal allergic rhinitis and the study has completed.
-
FDA approval · 2012-09-27FDA Approved: SINGULAIR — Supplemental Application (Organon LLC)
FDA approved a supplemental application for Singulair (montelukast sodium) submitted by Organon LLC.
-
CLINICAL_TRIALS trial_result · 2012-09-26Clinical Trial Update: A Study to Evaluate the Safety and Effectiveness of a Nasal Spray to Treat Seasonal Allergies [Phase 3]
Phase 3 trial evaluated the safety and effectiveness of a nasal spray for seasonal allergic rhinitis; results have been completed and posted…
-
CLINICAL_TRIALS trial_result · 2012-09-07Clinical Trial Update: A Study Evaluating the Safety and Effectiveness of a Nasal Spray to Treat Seasonal Allergies [Phase 3]
Phase 3 trial results evaluating a nasal spray for seasonal allergic rhinitis have been completed, with results posted in 2012.
-
CLINICAL_TRIALS trial_result · 2012-09-07Clinical Trial Update: A Study to Evaluate the Safety and Effectiveness of a Nasal Spray to Treat Seasonal Allergies [Phase 3]
A Phase 3 trial evaluating a nasal spray for seasonal allergic rhinitis has completed and posted results.
-
FDA approval · 2012-08-23FDA Approved: ALLEGRA-D ALLERGY AND CONGESTION — Supplemental Application (Chattem, Inc.)
FDA approved a supplemental application for Allegra-D Allergy and Congestion (fexofenadine HCl and pseudoephedrine HCl). The submission was …
-
CLINICAL_TRIALS trial_result · 2012-08-23Clinical Trial Update: Seasonal Allergic Rhinitis Study [Phase 2]
Phase 2 clinical trial update for Seasonal Allergic Rhinitis, sponsored by the University of East Anglia; the study addressing seasonal alle…
-
CLINICAL_TRIALS trial_result · 2012-08-23Clinical Trial Update: Treatment of Olfactory Dysfunction in Seasonal Allergic Rhinitis [Phase 4]
Phase 4 clinical trial evaluating treatment of olfactory dysfunction in Seasonal Allergic Rhinitis was terminated; results were posted in 20…
-
CLINICAL_TRIALS trial_result · 2012-08-15Clinical Trial Update: The Effect of Nasal Carbon Dioxide (CO2) Used As-Needed in the Symptomatic Treatment of Seasonal Allergic Rhinitis [Phase 2]
This clinical trial update reports the completion of a Phase 2 study evaluating nasal carbon dioxide as-needed for symptomatic relief in sea…
-
CLINICAL_TRIALS trial_result · 2012-08-15Clinical Trial Update: The Effect of Nasal Carbon Dioxide (CO2) in the Symptomatic Treatment of Seasonal Allergic Rhinitis [Phase 2]
Phase 2 trial results evaluating nasal administration of carbon dioxide (CO2) for symptomatic relief in seasonal allergic rhinitis.
-
FDA approval · 2012-08-10FDA Approved: DYMISTA — Supplemental Application (Viatris Specialty LLC)
FDA approved a supplemental application for DYMISTA (azelastine hydrochloride and fluticasone propionate) submitted by Viatris Specialty LLC…
-
FDA approval · 2012-08-06FDA Approved: MONTELUKAST SODIUM — Original Application (Dr.Reddy's Laboratories Limited)
FDA approves the original ANDA for Montelukast sodium from Dr. Reddy's Laboratories Limited, establishing a generic Montelukast sodium produ…
-
FDA approval · 2012-08-06FDA Approved: MONTELUKAST SODIUM — Original Application (Dr.Reddy's Laboratories Limited)
FDA approved the original application for Montelukast Sodium from Dr. Reddy's Laboratories Limited (ANDA 201581). This approval makes Montel…
-
FDA approval · 2012-08-03FDA Approved: MONTELUKAST SODIUM — Original Application (Rising Pharma Holdings, Inc.)
FDA approved the original application for a generic montelukast sodium product from Rising Pharma Holdings, Inc. under ANDA 202468.